SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Indications -- Cancer -- Ignore unavailable to you. Want to Upgrade?


To: Ian@SI who wrote (749)4/19/2005 6:26:41 PM
From: zeta1961  Read Replies (1) | Respond to of 1840
 
Ian, Interesting..ASCO de-embargoed its abstract release..

It will be a contest between ONXX/Bayer's molecule and Suten..PO'd me last year and '03 when ONXX's pps was being buoyed by the investment houses..at least PFE is making dough and has plenty of it..

DNA like pop?..how good are they in kahoots with the analysts and ASCO<g>..off the cuff..nothing supporting this claim..

Zeta